CDKN1B Loss Fuels ER Therapy Resistance in Breast Cancer
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and ...
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and ...
In a groundbreaking study poised to redefine breast cancer therapy, researchers have uncovered the remarkable potential of combining ferulic acid, ...
Breast cancer remains one of the leading causes of cancer-related mortality among women globally. Recent studies have identified distinct molecular ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine